Tildrakizumab shows promise as psoriasis treatment Merck reports in a phase I trial that its new monoclonal antibody, tildrakizumab, reduces psoriasis symptoms.…
How the pharmaceutical industry is contributing to antimicrobial resistance Through poor practices, the pharmaceutical industry is adding to the problem of antimicrobial resistance instead of helping to solve it.…
AstraZeneca spins out early-stage R&D for antibiotic compoundsAstraZeneca is creating a standalone subsidiary to work exclusively on early-stage antibiotics research and development, the company has announced.…
GSK and Novartis wrap up multibillion pound business dealGlaxoSmithKline and Novartis have completed their three-prong multibillion pound business transaction, the companies have announced.…
Licensing deal will allow paediatric HIV drug to be used more widelyChildren with HIV in developing countries will now have access to generic paediatric formulations of raltegravir following a licence agreement with Merck.…
Pharmaceutical companies often violate drug advertising codes, study finds The pharmaceutical industry’s systems for self-regulation of drug advertising and marketing are weak, according to a study published in PLoS Medicine.…
Infliximab biosimilars to launch in the UK as innovator product reaches patent expiryNapp Pharmaceuticals and Hospira will both launch biosimilars of Janssen Biologic’s Remicade in the UK after its patent expires on 24 February 2015.…
US healthcare groups recommend ways of tackling ongoing drug shortages Recommendations for addressing ongoing shortages of essential medicines have been made by a group of US healthcare organisations.…
Drug withdrawal delays are causing avoidable deaths, investigation finds The average time it has taken for a drug to be withdrawn following deaths attributable to it has remained constant at four years since the middle of the last century.…
Rolling out hepatitis C treatments will be costly The new generation of heptatitis C antivirals is highly effective, but the drugs’ expense will put pressure on healthcare providers.…